EUVIMEDEUVIMED entdecken
Crossref

THE ROLE OF MTOR IN THE DEVELOPMENT OF XENOPUS Laevis AND ITS INTERSECTION WITH DYRK1A

Shah, Devyani

VCU Scholars Compass (Virginia Commonwealth University) · 01.01.2025

DOI: 10.25772/5z08-zz55 ↗

Kurz gefasst

Fachartikel in der Zeitschrift VCU Scholars Compass (Virginia Commonwealth University), erschienen am 01.01.2025. Verfasst von Shah und 1 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Down Syndrome, caused by trisomy of chromosome 21, is the most common genetic cause of intellectual disability and is associated with craniofacial anomalies. Among the triplicated genes, DYRK1A is a key contributor to the syndrome’s neurodevelopmental and craniofacial abnormalities. Recent studies suggest that DYRK1A may interact with signaling pathways, including the mTOR pathway, which regulates cell growth, proliferation, and differentiation. However, whether this is true in embryos is unknown. Using the developmental model Xenopus laevis, this study examines 1) whether inhibition of mTORC1 causes developmental differences and 2) whether Dyrk1a inhibition exacerbates differences caused by inhibition of mTOR. Exposure to Rapamycin, an mTOR inhibitor, significantly reduced body length and midface. Morphometric analysis of craniofacial shape revealed that the changes in the midface were consistent with developmental delay rather than morphological defects. Cranial cartilage analysis revealed changes in the lower jaw that were consistent with a delay in development. Time-sensitive experiments showed that the effects of rapamycin were profound during a specific period of development when specification of organs and tissues, including the face, occurs. Finally, I determined that the reduction of midface size due to rapamycin exposure was made worse when these embryos were also exposed to a Dyrk1a inhibitor. These results are the first to suggest that Dyrk1a could modulate the mTOR pathway in embryos. The preliminary experiments have been a critical step to pave the way for testing whether rapamycin could be a feasible method to correct some of the developmental alterations in animal models with excess Dyrk1a.

Schlagwörter

Down syndromeDYRK1AmTOR signalingmTORC1 inhibitionrapamycincraniofacial developmentmidfacedevelopmental delaycranial cartilageXenopus laevis embryos

Zitieren

APA

Shah, & Devyani (2025). THE ROLE OF MTOR IN THE DEVELOPMENT OF XENOPUS Laevis AND ITS INTERSECTION WITH DYRK1A. VCU Scholars Compass (Virginia Commonwealth University). https://doi.org/10.25772/5z08-zz55

Vancouver

Shah, Devyani. THE ROLE OF MTOR IN THE DEVELOPMENT OF XENOPUS Laevis AND ITS INTERSECTION WITH DYRK1A. VCU Scholars Compass (Virginia Commonwealth University). 2025. doi:10.25772/5z08-zz55

BibTeX
@article{Shah2025,
  author = {Shah and Devyani},
  title = {THE ROLE OF MTOR IN THE DEVELOPMENT OF XENOPUS Laevis AND ITS INTERSECTION WITH DYRK1A},
  journal = {VCU Scholars Compass (Virginia Commonwealth University)},
  year = {2025},
  doi = {10.25772/5z08-zz55}
}
Kostenlos starten →